CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
November 19, 2020
Connected Content
A related article has been published:
CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell–targeted therapies
A commentary has been published:
Monoclonal IgM and neuropathy: not always anti-MAG
Citation
CANOMAD syndrome. Blood 2020; 136 (21): 2481. doi: https://doi.org/10.1182/blood.2020009573
Download citation file: